LTR Pharma Limited (AU:LTP) has released an update.
LTR Pharma Limited has announced the issuance of new unquoted equity securities, including options with various expiry dates and prices and performance rights, set to be issued in April 2024. These securities are part of an employee incentive scheme and are not intended to be quoted on the ASX. This strategic move could be of interest to investors monitoring company growth and employee compensation trends.
For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.
